Search

Your search keyword '"Futreal A"' showing total 382 results

Search Constraints

Start Over You searched for: Author "Futreal A" Remove constraint Author: "Futreal A" Topic medicine.disease Remove constraint Topic: medicine.disease
382 results on '"Futreal A"'

Search Results

1. <scp>Mouse‐INtraDuctal</scp> ( <scp>MIND</scp> ): an in vivo model for studying the underlying mechanisms of <scp>DCIS</scp> malignancy

2. Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer

3. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

4. Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

5. Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia

6. Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features

7. Summary from the Kidney Cancer Association’s Inaugural Think Thank: Coalition for a Cure

8. Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study

9. Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

10. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas

11. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma

12. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

13. Pan-cancer analysis of whole genomes

14. Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity

15. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

16. Abstract P4-07-04: Genomic analysis of paired DCIS and subsequent recurrence to assess clonal relatedness in screen detected DCIS

17. Immuno-genomic landscape of osteosarcoma

18. Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative

19. Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN)

20. Gut Microbiome Features Associated with Liver Fibrosis in Hispanics, a Population at High Risk for Fatty Liver Disease

21. Immunogenomic Intertumor Heterogeneity Across Primary and Metastatic Sites in a Patient With Lung Adenocarcinoma

22. Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

23. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

24. Sex differences in oncogenic mutational processes

25. Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics

26. Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer

27. Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant

28. PRDM16s transforms megakaryocyte-erythroid progenitors into myeloid leukemia–initiating cells

29. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma

30. Abstract P3-07-01: Towards a therapeutically relevant subtyping scheme for triple-negative breast cancer (TNBC), profiling results from A Randomized, TNBC Enrolling trial to confirm Molecular profiling Improves Survival (ARTEMIS)

31. The circular RNome of primary breast cancer

32. Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma

33. Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

34. Genomic profiling defines variable clonal relatedness between invasive breast cancer and primary ductal carcinoma in situ

35. Genomic and TCR Repertoire Intratumor Heterogeneity of Small-cell Lung Cancer and its Impact on Survival

36. The histologic phenotype of lung cancers may be driven by transcriptomic features rather than genomic characteristics

37. Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications

38. 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy

39. 9p21 Loss Defines the Evolutionary Patterns of Aggressive Renal Cell Carcinomas

40. 744 Single cell profiling of acute myeloid leukemia (AML) and its microenvironment reveals a CD8 continuum and adaptable T cell plasticity in response to PD-1 blockade-based therapy

41. Whole-Genome Sequencing of Common Salivary Gland Carcinomas: Subtype-Restricted and Shared Genetic Alterations

42. Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer

43. Genomic profiling of multifocal intrahepatic cholangiocarcinoma reveals intraindividual concordance of genetic alterations

44. Distinct T cell receptor repertoire diversity of clinically defined high-grade serous ovarian cancer treatment subgroups

45. Fidelity of peripheral blood for monitoring genomics and tumor immune-microenvironment in myelodysplastic syndromes

46. Evolution of DNA methylome from precancer to invasive lung adenocarcinoma

47. Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features

48. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy

49. Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer

50. A computational network approach to identify predictive biomarkers and therapeutic combinations for anti-PD-1 immunotherapy in cancer

Catalog

Books, media, physical & digital resources